| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918903 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
This novel technique employing standard linear accelerators to deliver an extreme hypofractionated schedule of radiotherapy is feasible, well tolerated and shows excellent pathologic and biochemical control.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrew Loblaw, Patrick Cheung, Laura D'Alimonte, Andrea Deabreu, Alexandre Mamedov, Liying Zhang, Colin Tang, Harvey Quon, Suneil Jain, Geordi Pang, Robert Nam,